Vandana Singh
·
March 7, 2025
Benzinga
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
read more
April 26, 2025
April 22, 2025
Barchart
April 21, 2025
April 2, 2025
Fortune